Skip to main content
Erschienen in: Zeitschrift für Rheumatologie 3/2019

24.04.2018 | Originalien

Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: an updated meta-analysis

verfasst von: Y. H. Lee, MD, PhD, G. G. Song

Erschienen in: Zeitschrift für Rheumatologie | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Objective

The aim of this study was to determine whether interleukin-23R (IL-23R) polymorphisms are associated with susceptibility to ankylosing spondylitis (AS).

Methods

Meta-analyses were conducted to determine the associations between IL-23R polymorphisms and AS susceptibility in Europeans, Asians, and all subjects combined.

Results

A total of 17 studies (21 separate comparisons) were included in this meta-analysis. The meta-analysis revealed a significant association between AS and the two alleles of the rs11209032 polymorphism in all study subjects (odds ratio [OR] = 1.160, 95% confidence interval [CI] = 1.091–1.204, P < 0.001). Stratification by ethnicity identified a significant association between this polymorphism and AS in Europeans (OR = 1.234, 95% CI = 1.159–1.313, P < 0.001), but not in Asians (OR = 1.003, 95% CI = 0.920–1.219, P = 0.942). Meta-analyses of the rs1004819, rs10489629, rs1343151, rs1495965, rs7517847, and rs11465804 polymorphisms showed the same pattern as shown for rs11209032. The meta-analysis also revealed a significant association between the two alleles of the rs2201841 and rs11209026 polymorphisms and the risk of developing AS in Europeans, but not in Asians. Interestingly, the rs10889677 polymorphism was not found to be associated with AS susceptibility in either Europeans or Asians.

Conclusions

This meta-analysis showed that several IL-23R polymorphisms are associated with the development of AS in Europeans.
Literatur
1.
Zurück zum Zitat Brown MA, Wordsworth BP, Reveille JD (2002) Genetics of ankylosing spondylitis. Clin Exp Rheumatol 20:S43–49 PubMed Brown MA, Wordsworth BP, Reveille JD (2002) Genetics of ankylosing spondylitis. Clin Exp Rheumatol 20:S43–49 PubMed
2.
Zurück zum Zitat Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2005) Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 50:453–459 CrossRef Lee YH, Rho YH, Choi SJ, Ji JD, Song GG (2005) Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 50:453–459 CrossRef
3.
Zurück zum Zitat Brown M (2007) Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology 47:132–137 CrossRef Brown M (2007) Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology 47:132–137 CrossRef
4.
Zurück zum Zitat Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957 CrossRef Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA, Sedgwick JD, Cua DJ (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957 CrossRef
5.
Zurück zum Zitat Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139–145 CrossRef Steinman L (2007) A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat Med 13:139–145 CrossRef
6.
Zurück zum Zitat Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463 CrossRef Duerr RH, Taylor KD, Brant SR, Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, Abraham C, Regueiro M, Griffiths A (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314:1461–1463 CrossRef
7.
Zurück zum Zitat Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273–290 CrossRef Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon R, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273–290 CrossRef
8.
Zurück zum Zitat Ruan WF, Xie JT, Jin Q, Wang WD, Ping AS (2018) The diagnostic and prognostic role of interleukin 12B and Interleukin 6R gene polymorphism in patients with ankylosing spondylitis. J Clin Rheumatol 24:18–24 PubMed Ruan WF, Xie JT, Jin Q, Wang WD, Ping AS (2018) The diagnostic and prognostic role of interleukin 12B and Interleukin 6R gene polymorphism in patients with ankylosing spondylitis. J Clin Rheumatol 24:18–24 PubMed
9.
Zurück zum Zitat Su SS, Wang SL, Lu LJ, Lin L (2016) Association of interleukin-23 receptor gene single nucleotide polymorphisms with ankylosing spondylitis. Ann Clin Lab Sci 46:470–473 PubMed Su SS, Wang SL, Lu LJ, Lin L (2016) Association of interleukin-23 receptor gene single nucleotide polymorphisms with ankylosing spondylitis. Ann Clin Lab Sci 46:470–473 PubMed
10.
Zurück zum Zitat Daryabor G, Mahmoudi M, Jamshidi A, Nourijelyani K, Amirzargar A, Ahmadzadeh N, Farhadi E, Nicknam MH (2014) Determination of IL-23 receptor gene polymorphism in Iranian patients with ankylosing spondylitis. Eur Cytokine Netw 25:24–29 PubMed Daryabor G, Mahmoudi M, Jamshidi A, Nourijelyani K, Amirzargar A, Ahmadzadeh N, Farhadi E, Nicknam MH (2014) Determination of IL-23 receptor gene polymorphism in Iranian patients with ankylosing spondylitis. Eur Cytokine Netw 25:24–29 PubMed
11.
Zurück zum Zitat Dong H, Li Q, Zhang Y, Tan W, Jiang Z (2013) IL23R gene confers susceptibility to ankylosing spondylitis concomitant with uveitis in a Han Chinese population. PLoS ONE 8:e67505 CrossRef Dong H, Li Q, Zhang Y, Tan W, Jiang Z (2013) IL23R gene confers susceptibility to ankylosing spondylitis concomitant with uveitis in a Han Chinese population. PLoS ONE 8:e67505 CrossRef
12.
Zurück zum Zitat Qian BP, Jiang J, Ji ML, Wang B, Yu Y, Qiu Y (2013) Lack of associations between two previously identified susceptible single nucleotide polymorphisms of interleukin-23 receptor gene and ankylosing spondylitis: a replication study in a Chinese Han population. BMC Musculoskelet Disord 14:190 CrossRef Qian BP, Jiang J, Ji ML, Wang B, Yu Y, Qiu Y (2013) Lack of associations between two previously identified susceptible single nucleotide polymorphisms of interleukin-23 receptor gene and ankylosing spondylitis: a replication study in a Chinese Han population. BMC Musculoskelet Disord 14:190 CrossRef
13.
Zurück zum Zitat Chen C, Zhang X, Li J, Wang Y (2012) Associations of IL-23R polymorphisms with ankylosing spondylitis in East Asian population: a new case-control study and a meta-analysis. Int J Immunogenet 39:126–130 CrossRef Chen C, Zhang X, Li J, Wang Y (2012) Associations of IL-23R polymorphisms with ankylosing spondylitis in East Asian population: a new case-control study and a meta-analysis. Int J Immunogenet 39:126–130 CrossRef
14.
Zurück zum Zitat Wong RH, Wei JC, Huang CH, Lee HS, Chiou SY, Lin SH, Cai YW, Hung PH, Wang MF, Yang SF (2012) Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis. J Rheumatol 39:135–140 CrossRef Wong RH, Wei JC, Huang CH, Lee HS, Chiou SY, Lin SH, Cai YW, Hung PH, Wang MF, Yang SF (2012) Association of IL-12B genetic polymorphism with the susceptibility and disease severity of ankylosing spondylitis. J Rheumatol 39:135–140 CrossRef
15.
Zurück zum Zitat Wang X, Huang J, Lin Z, Liao Z, Li C, Wei Q, Jiang Y, Zhao L, Gu J (2010) Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients. Rheumatol Int 30:955–959 CrossRef Wang X, Huang J, Lin Z, Liao Z, Li C, Wei Q, Jiang Y, Zhao L, Gu J (2010) Single-nucleotide polymorphisms and expression of IL23R in Chinese ankylosing spondylitis patients. Rheumatol Int 30:955–959 CrossRef
16.
Zurück zum Zitat Davidson SI, Wu X, Liu Y et al (2009) Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 60:3263–3268 CrossRef Davidson SI, Wu X, Liu Y et al (2009) Association of ERAP1, but not IL23R, with ankylosing spondylitis in a Han Chinese population. Arthritis Rheum 60:3263–3268 CrossRef
17.
Zurück zum Zitat Pimentel-Santos FM, Ligeiro D, Matos M et al (2009) Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol 27:800–806 PubMed Pimentel-Santos FM, Ligeiro D, Matos M et al (2009) Association of IL23R and ERAP1 genes with ankylosing spondylitis in a Portuguese population. Clin Exp Rheumatol 27:800–806 PubMed
18.
Zurück zum Zitat Safrany E, Pazar B, Csongei V, Jaromi L, Polgar N, Sipeky C, Horvath IF, Zeher M, Poor G, Melegh B (2009) Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples. Scand J Immunol 70:68–74 CrossRef Safrany E, Pazar B, Csongei V, Jaromi L, Polgar N, Sipeky C, Horvath IF, Zeher M, Poor G, Melegh B (2009) Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples. Scand J Immunol 70:68–74 CrossRef
19.
Zurück zum Zitat Sung IH, Kim TH, Bang SY, Kim TJ, Lee B, Peddle L, Rahman P, Greenwood CM, Hu P, Inman RD (2009) IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol 36:1003–1005 CrossRef Sung IH, Kim TH, Bang SY, Kim TJ, Lee B, Peddle L, Rahman P, Greenwood CM, Hu P, Inman RD (2009) IL-23R polymorphisms in patients with ankylosing spondylitis in Korea. J Rheumatol 36:1003–1005 CrossRef
20.
Zurück zum Zitat Karaderi T, Harvey D, Farrar C, Appleton LH, Stone MA, Sturrock RD, Brown MA, Wordsworth P, Pointon JJ (2009) Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 48:386–389 CrossRef Karaderi T, Harvey D, Farrar C, Appleton LH, Stone MA, Sturrock RD, Brown MA, Wordsworth P, Pointon JJ (2009) Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology (Oxford) 48:386–389 CrossRef
21.
Zurück zum Zitat Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ, Vilches C, Gonzalez-Gay MA, Martin J (2008) The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 67:1451–1454 CrossRef Rueda B, Orozco G, Raya E, Fernandez-Sueiro JL, Mulero J, Blanco FJ, Vilches C, Gonzalez-Gay MA, Martin J (2008) The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis 67:1451–1454 CrossRef
22.
Zurück zum Zitat Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39:1329 CrossRef Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, Kwiatkowski DP, McCarthy MI, Ouwehand WH, Samani NJ (2007) Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 39:1329 CrossRef
23.
Zurück zum Zitat Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP (2008) Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheumatol 58:1020–1025 CrossRef Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP (2008) Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheumatol 58:1020–1025 CrossRef
24.
Zurück zum Zitat Reveille JD, Sims A‑M, Danoy P, Evans DM, Leo P, Pointon JJ, Jin R, Zhou X, Bradbury LA, Appleton LH (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123 CrossRef Reveille JD, Sims A‑M, Danoy P, Evans DM, Leo P, Pointon JJ, Jin R, Zhou X, Bradbury LA, Appleton LH (2010) Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 42:123 CrossRef
25.
Zurück zum Zitat Lee YH, Choi SJ, Ji JD, Song GG (2012) Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res 61:143–149 CrossRef Lee YH, Choi SJ, Ji JD, Song GG (2012) Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis. Inflamm Res 61:143–149 CrossRef
26.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med 6:e1000097 CrossRef Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med 6:e1000097 CrossRef
27.
Zurück zum Zitat Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558 CrossRef Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558 CrossRef
28.
Zurück zum Zitat Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533–1537 CrossRef Egger M, Smith GD, Phillips AN (1997) Meta-analysis: principles and procedures. BMJ 315:1533–1537 CrossRef
29.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188 CrossRef DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188 CrossRef
30.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634 CrossRef Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634 CrossRef
31.
Zurück zum Zitat Linden SVD, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheumatol 27:361–368 CrossRef Linden SVD, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. Arthritis Rheumatol 27:361–368 CrossRef
32.
Zurück zum Zitat McKenzie BS, Kastelein RA, Cua DJ (2006) Understanding the IL-23–IL-17 immune pathway. Trends Immunol 27:17–23 CrossRef McKenzie BS, Kastelein RA, Cua DJ (2006) Understanding the IL-23–IL-17 immune pathway. Trends Immunol 27:17–23 CrossRef
33.
Zurück zum Zitat Zhang X‑Y, Zhang H‑J, Zhang Y, Fu Y‑J, He J, Zhu L‑P, Wang S‑H, Liu L (2006) Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics 57:934–943 CrossRef Zhang X‑Y, Zhang H‑J, Zhang Y, Fu Y‑J, He J, Zhu L‑P, Wang S‑H, Liu L (2006) Identification and expression analysis of alternatively spliced isoforms of human interleukin-23 receptor gene in normal lymphoid cells and selected tumor cells. Immunogenetics 57:934–943 CrossRef
34.
Zurück zum Zitat Kivitz A, Blanco R, Maradiaga M, Sieper J, Tahir H, Andersson M, Readie A, Porter B (2016) Secukinumab provides sustained improvement in physical, function, health-related quality of life, fatigue, and work productivity in patients with active psoriatic arthritis: 52-week results from an international phase 3 trial. J Clin Rheumatol 22:142–143 Kivitz A, Blanco R, Maradiaga M, Sieper J, Tahir H, Andersson M, Readie A, Porter B (2016) Secukinumab provides sustained improvement in physical, function, health-related quality of life, fatigue, and work productivity in patients with active psoriatic arthritis: 52-week results from an international phase 3 trial. J Clin Rheumatol 22:142–143
35.
Zurück zum Zitat Baeten D, Sieper J, Braun J et al (2015) Secukinumab, an interleukin-17A Inhibitor, in ankylosing spondylitis. N Engl J Med 373:2534–2548 CrossRef Baeten D, Sieper J, Braun J et al (2015) Secukinumab, an interleukin-17A Inhibitor, in ankylosing spondylitis. N Engl J Med 373:2534–2548 CrossRef
Metadaten
Titel
Associations between interleukin-23R polymorphisms and ankylosing spondylitis susceptibility: an updated meta-analysis
verfasst von
Y. H. Lee, MD, PhD
G. G. Song
Publikationsdatum
24.04.2018
Verlag
Springer Medizin
Erschienen in
Zeitschrift für Rheumatologie / Ausgabe 3/2019
Print ISSN: 0340-1855
Elektronische ISSN: 1435-1250
DOI
https://doi.org/10.1007/s00393-018-0472-z

Weitere Artikel der Ausgabe 3/2019

Zeitschrift für Rheumatologie 3/2019 Zur Ausgabe

Leitthema

Infektionen

Update Rheumatologie

RA: Therapie

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.